Expanded US patent approval for DiviTum™

Biovica has received expanded patent approval for the DiviTum™ kit-technology by the United States Patent and Trademark office. The patent protection for DiviTum™ now includes both the method and kit. DiviTum™ has patent protection in the US & Canada and across Europe, in total 49 countries. Biovica has developed DiviTum™, a non-invasive blood test, for [...]

2017-01-03T10:41:14+00:00 August 31st, 2016 09:00|Press Release|